The EU’s medicines watchdog said on Friday that it expects Johnson and Johnson to submit an application for its coronavirus vaccine “shortly” after it published “promising” results from a large trial.
“We’ve just heard some promising results from the Janssen vaccine, which hope to be submitted shortly to us,” European Medicines Agency chief Emer Cooke told a press conference, referring to Johnson & Johnson’s European subsidiary Jansen-Cilag.
“This is currently subject to a rolling review which precedes the formal marketing authorisation application submission,” said Cooke.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
EU regulator expects J&J vaccine application ‘shortly’ (2021, January 29)
retrieved 30 January 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- No Omicron cases in India yet, says health minister Mansukh Mandaviya - December 1, 2021
- Covid infection linked with increased complications in pregnancy, birth: Study - December 1, 2021
- Karnataka CM to meet Union Health Minister to discuss administration of booster dose of COVID vaccine - December 1, 2021
- Four passengers from UK, Netherlands test positive for Covid, samples sent for genome sequencing - December 1, 2021
- Testing kits can detect Omicron: Mylab - November 30, 2021
- Can RT-PCR tests detect Omicron variant infection? - November 30, 2021
- Moderna CEO warns COVID-19 shots less effective against Omicron, spooks markets - November 30, 2021
- Mandatory face masks in force as Omicron cases rise to 14 in UK - November 30, 2021
- Delhi: Seven Covid deaths in November - November 30, 2021
- 116 more test COVID positive at Karnataka’s medical college - November 26, 2021